These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39196671)

  • 1. A Multifaceted Assessment of Benign Prostatic Hyperplasia Practice and AUA Guideline Adherence.
    Welliver C; MacLachlan LS; Riggs S; Kukreja JB; Miles-Thomas J
    Urol Pract; 2024 Nov; 11(6):950-955. PubMed ID: 39196671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population.
    Strope SA; Elliott SP; Saigal CS; Smith A; Wilt TJ; Wei JT;
    Urology; 2011 Jul; 78(1):3-9. PubMed ID: 21601254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Do urologists apply benign prostatic hyperplasia clinical practice guidelines? Survey on the complementary investigation request modalities in France].
    de la Taille A; Desgrandchamps F; Saussine C; Lukacs B; Haillot O
    Prog Urol; 2004 Jun; 14(3):320-5. PubMed ID: 15373173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States.
    Gee WF; Holtgrewe HL; Albertsen PC; Litwin MS; Manyak MJ; O'Leary MP; Painter MR
    J Urol; 1995 Jul; 154(1):205-6. PubMed ID: 7539861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familiarity and self-reported compliance with American Urological Association best practice recommendations for use of thromboembolic prophylaxis among American Urological Association members.
    Sterious S; Simhan J; Uzzo RG; Gershman B; Li T; Devarajan K; Canter D; Walton J; Fogg R; Ginzburg S; Corcoran A; Smaldone MC; Kutikov A
    J Urol; 2013 Sep; 190(3):992-8. PubMed ID: 23538239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An observational analysis of provider adherence to AUA guidelines on the management of benign prostatic hyperplasia.
    Auffenberg GB; Gonzalez CM; Wolf JS; Clemens JQ; Meeks W; McVary KT
    J Urol; 2014 Nov; 192(5):1483-8. PubMed ID: 24931806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to AUA guidelines for the work-up, medical management, surgical evaluation and treatment of BPH: Work from a quality improvement collaborative.
    Wahlstedt E; Graves JL; Wahlstedt J; D'Alessandro A; Cranford W; Freidberg NA; Bhalodi A; Bell JR; James A; Bylund J; Strup SE; Harris A
    Low Urin Tract Symptoms; 2024 Jul; 16(4):e12526. PubMed ID: 38858826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer.
    Fawzy A; Fontenot C; Guthrie R; Baudier MM
    Fam Med; 1997 May; 29(5):321-5. PubMed ID: 9165283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians.
    Collins MM; Barry MJ; Bin L; Roberts RG; Oesterling JE; Fowler FJ
    J Gen Intern Med; 1997 Apr; 12(4):224-9. PubMed ID: 9127226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
    Kaplan SA; Olsson CA; Te AE
    J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management.
    Lerner LB; McVary KT; Barry MJ; Bixler BR; Dahm P; Das AK; Gandhi MC; Kaplan SA; Kohler TS; Martin L; Parsons JK; Roehrborn CG; Stoffel JT; Welliver C; Wilt TJ
    J Urol; 2021 Oct; 206(4):806-817. PubMed ID: 34384237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller EE; Matlaga BR; McVary K
    Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):269-273. PubMed ID: 34545201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia].
    Lebdai S; Rahmène Azzouzi A; Delongchamps NB; Benchikh A; Campeggi A; Cornu JN; Dumonceau O; Faix A; Fourmarier M; Haillot O; Lukacs B; Mathieu R; Misrai V; Robert G; de La Taille A; Descazeaud A
    Prog Urol; 2015 Jan; 25(1):47-53. PubMed ID: 25453357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States.
    Clemens JQ; Goldman HB; Zou KH; Luo X; Russell D; Chapman DS; Esinduy CB; Anger JT
    J Urol; 2016 Jul; 196(1):173-8. PubMed ID: 26872842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines.
    Paick JS; Kim SW; Ku JH
    Yonsei Med J; 2007 Apr; 48(2):281-8. PubMed ID: 17461528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the Management of Benign Prostatic Hyperplasia: The Role of Electronic Health Record Patient Portal Distribution of the International Prostate Symptom Score.
    Zhu D; Mali K; Bandari J; Jain RK; Quarrier SO
    Urol Pract; 2024 Jul; 11(4):709-715. PubMed ID: 38899670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National trends in the use of PSA, urinalysis, and digital rectal exam for evaluation of lower urinary tract symptoms in men.
    Doolin J; Reese ZA; Mukamal KJ
    World J Urol; 2021 Mar; 39(3):855-860. PubMed ID: 32448971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The American Urological Association 2003 guideline on management of benign prostatic hyperplasia: a Canadian opinion.
    Nickel JC; Saad F
    Can J Urol; 2004 Apr; 11(2):2186-93. PubMed ID: 15182407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty.
    Seftel AD; Rosen RC; Rosenberg MT; Sadovsky R
    Int J Clin Pract; 2008 Apr; 62(4):614-22. PubMed ID: 18266709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.